Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 6, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	6,686	3,547	1,797	2,360	3,139	4,821
Market Cap Growth	235.72%	97.45%	-23.88%	-24.82%	-34.88%	41.53%
Enterprise Value	6,512	3,413	1,818	2,294	2,857	4,456
Last Close Price	48.28	25.22	14.30	22.39	29.48	46.19
PE Ratio	44.49	-	-	-	-	-
PS Ratio	8.25	5.75	678.12	11.96	14.38	47.07
PB Ratio	15.99	9.47	12.60	10.03	8.36	15.92
P/TBV Ratio	16.01	10.39	13.61	11.03	9.05	16.47
P/FCF Ratio	27.94	30.40	-	-	-	44.06
P/OCF Ratio	26.52	26.56	-	-	-	37.99
EV/Sales Ratio	8.08	5.53	686.02	11.63	13.09	43.51
EV/EBITDA Ratio	25.77	37.52	-	-	-	-
EV/EBIT Ratio	29.33	46.65	-	-	-	-
EV/FCF Ratio	27.22	29.25	-	-	-	40.72
Debt / Equity Ratio	1.22	1.48	4.46	1.34	0.20	0.06
Debt / EBITDA Ratio	2.01	5.36	-	-	-	-
Debt / FCF Ratio	2.14	4.74	-	-	-	0.17
Asset Turnover	0.83	0.66	0.00	0.33	0.35	0.22
Quick Ratio	3.27	4.73	6.57	3.75	2.67	2.58
Current Ratio	3.38	4.86	6.74	3.95	2.92	2.63
Return on Equity (ROE)	75.50%	8.67%	-254.98%	-59.33%	-42.68%	-32.36%
Return on Assets (ROA)	14.35%	4.87%	-39.43%	-17.58%	-15.91%	-15.11%
Return on Invested Capital (ROIC)	82.98%	16.53%	-187.71%	-101.05%	-180.86%	-127.38%
Return on Capital Employed (ROCE)	23.90%	8.30%	-58.00%	-31.10%	-32.30%	-26.40%
Earnings Yield	2.25%	-0.03%	-24.90%	-7.13%	-5.03%	-2.16%
FCF Yield	3.58%	3.29%	-25.10%	-11.48%	-5.40%	2.27%
Buyback Yield / Dilution	-10.94%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.